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ABSTRACT 
 
CLARIFYING THE INFLUENCE OF COMORBID DEPRESSION ON RESPONSE 
INHIBITION IN OBSESSIVE-COMPULSIVE DISORDER AND TRICHOTILLOMANIA 
 
by 
 
Gregory S. Berlin 
 
The University of Wisconsin-Milwaukee, 2016 
Under the Supervision of Professor Han Joo Lee, Ph.D. 
 
 
Response inhibition performance in Obsessive-Compulsive and Related Disorders (OCRDs) is 
emerging as a potential neurocognitive endophenotype of these disorders. A point of needed 
clarification, however, is how unique such performance is to the OCRD spectrum. Specifically, it 
is unknown whether comorbid depression, a disorder that frequently occurs with OCRDs (60-
80%) (Pallanti et al., 2011) and is also associated with cognitive deficits, can influence response 
inhibition observed in OCRDs. We sought to clarify whether response inhibition performance 
could be reliably accounted for OCRD symptomology (in obsessive compulsive disorder and 
trichotillomania specifically) even when taking into consideration the influence of comorbid 
depression. Additionally, we investigate the interplay between RI and associated OCRD factors 
in domains of impulsivity, incompleteness and life disability. We found that response inhibition 
performance is not accounted for OCRD symptomology in aggregate (i.e., OCD and 
trichotillomania), but is uniquely related to compulsion severity in the context of OCD. 
Additionally, response inhibition performance is largely unrelated to associated domains of 
impulsivity, incompleteness and overall life disability. 
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Introduction 
What are Obsessive-Compulsive and Related Disorders? 
 Obsessive Compulsive Disorder (OCD) is a debilitating psychiatric condition 
characterized by a pattern of intrusive, unwanted mental images or urges and repetitive behaviors 
or mental acts to reduce stress from such thoughts (DSM-5; American Psychiatric Association, 
2013). More specifically, intrusive, unwanted images/urges/thoughts are defined as obsessions, 
while repetitive behaviors/mental acts in response to such obsessions are referred to as 
compulsions (DSM-5; American Psychiatric Association, 2013). OCD is estimated to have a 
prevalence rate of 1.2-2.3% (Ruscio et al., 2010). OCD symptomology is among the ten leading 
causes of psychosocial impairment and is associated with detrimental impact on everyday 
functioning (Lopez & Murray, 1998). OCD symptoms, even at subthreshold levels, are evident 
in seemingly healthy samples and can lead to functional impairment (de Bruijn et al., 2010).  
 Trichotillomania (TTM), or “Hair-Pulling Disorder,” is characterized by the recurrent 
pulling out of one’s own hair, repeated attempts to stop such pulling, as well as clinically 
significant distress or impairment from this habit (DSM-5; American Psychiatric Association, 
2013). The 12-month prevalence of TTM is estimated at 1-2%, and there has been a reported 
gender preponderance of those affected (10:1, Females: Males) (Lochner et al., 2005). Though 
TTM is rarely accompanied by obsessional preoccupation, hair-pulling may be done in response 
to certain emotional states, or in response to a premonitory urge (Franklin et al., 2011). 
OCD and TTM are classified together in the Diagnostic and Statistical Manual of Mental 
Disorders-5 (DSM-5) as “Obsessive-Compulsive and Related Disorders (OCRDs)” along with 
such diagnoses as Body Dysmorphic Disorder (BDD), Skin-Picking Disorder (SPD) and 
Hoarding Disorder. These seemingly disparate conditions were grouped together based on 
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existing evidence regarding their symptom profiles, comorbidities, familiality, genetic and neural 
underpinnings, and treatment response (Phillips et al., 2010). In terms of phenomenology, for 
instance, TTM is grouped with OCD because hair pulling is thought to be a “body-focused 
repetitive behavior” (DSM-5; American Psychiatric Association, 2013). These changes were a 
major departure from DSM-IV where OCD was classified as an anxiety disorder and TTM was 
classified as an impulse-control disorder (Stein et al., 2010). Taken together, the changes in 
grouping for OCD and TTM represent a shift towards understanding these disorders 
dimensionally based on relatedness of symptoms, as well as examining a putative endophenotype 
that could characterize the dysfunction unique to the OC-Spectrum (Phillips et al., 2010; 
Chamberlain & Menzies, 2009).  
In a similar vein, symptoms of disorders along the OC-Spectrum are roughly grouped 
together under the National Institutes of Mental Health Research Domain Criteria initiative 
(NIMH-RDoC). The RDoC initiative is one that hopes to foster the development of cross-cutting 
symptom domains that are informed by findings in neurobiology and behavioral research 
(Cuthbert, 2014). RDoC groups OC-symptomology under “Positive Valence Symptoms” and 
within this category attempts to understand their diverse presentations as habit-based behaviors 
(NIMH, n.d.). These disorders are then studied jointly via neurobiological, cognitive, behavioral 
and self-report techniques.    
DSM and RDoC nosologic changes converge on the idea that disorders with seemingly 
different profiles may have common underlying pathological processes. Moreover, they support 
the notion that disparate disorders can be studied together to uncover common processes that 
underlie multiple symptomologies without clouding clear differences between diagnoses 
(Montague et al., 2012; Abramowitz & Jacoby, 2015).  
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In the spirit of this line of work, this project concurrently studies OCD and TTM to 
uncover similarities and differences between these disorders on targets of interest. OCD and 
TTM in particular share the important phenomenological characteristic of “irresistible urges to 
perform unwanted repetitive behavior” (Chamberlain et al., 2007b). The phenomenological link 
between TTM and OCD may be particularly important considering that other OC-Spectrum 
conditions, such as BDD, do not always have as clear repetitive behaviors (Browne et al., 2014; 
Frare et al., 2004). Additional points of evidence from familiality (Bienvenu et al., 2000), 
treatment response (Chamberlain et al., 2007b), and genetic risk factors (Monzani et al., 2014) 
have informed the putative connection between OCD and TTM. Of course, these points are not 
meant to muddle important differences between the conditions (Chamberlain et al., 2007b). 
However, these evidence suggest that studying OCD and TTM together may aid in clarifying 
cross-cutting symptom factors relevant to a broader OC-Spectrum. 
What is Response Inhibition? Description and Theories 
Response inhibition (RI) is a cognitive process that refers to the ability to inhibit or 
suppress responses that are inappropriate or no longer required (Verburggen & Logan, 2009). It 
is a cognitive process that is key to many aspects of executive function, especially working 
memory, and is paramount to flexible behavior across different environments (Diamond, 2013). 
RI, as used in this project, refers to a faculty central to the deliberate inhibition of inappropriate 
motor responses. Real-world analogies of RI abound, such as stepping on the brakes in a car 
when a traffic light suddenly changes.   
To understand RI fully, one needs to understand its relationship to other varied forms or 
cognitive and motor control. RI is functionally different than other forms of inhibitory control 
such as reactive inhibition, where inhibition is a side effect of executing a tangential process 
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(i.e., response conflict, proactive inhibition in memory tasks). In addition, RI is differentiated 
from “bottom-up” inhibitory control where a distracting stimulus can grab one’s attention and 
inhibit an ongoing process regardless of conscious control (Diamond, 2013). RI is more 
appropriately characterized as “top-down” control, or, inhibition driven by active and focused 
control (Dalley et al., 2011).  
It is generally assumed that RI is a ballistic cognitive process. In other words, RI theory 
posits that some motoric actions, after a certain point of initiation, functionally cannot be stopped 
(Logan, 1994). The point at which a behavior transitions from focused control and into non-
inhibitable action is referred to as the point-of-no-return (Verbruggen & Logan, 2009). From this 
theory it follows that the strength of an inhibitory faculty, and any influence a paradigm exerts 
on manipulating successful inhibition, must come before this ballistic initiation is executed. 
Additionally, some RI researchers theorize that excitatory and inhibitory processes behind a 
motoric action are largely independent, and whether a response is inhibited depends on whether a 
“go” or “stop” process is stronger (Logan, 1994). This idea is what is referred to as a ‘horse-race’ 
model, because the success in inhibition is characterized as a ‘race’ between go and stop 
processes, and whichever process finishes first is thought to determine the success or failure of 
the inhibition attempt. 
Within RI are multiple inhibitory sub-processes, each of which is probed through a 
different measurement paradigm. First, one form of RI is action cancellation, which refers to the 
act of cancelling an ongoing response when a signal to stop emerges (Schachar et al., 2007). 
Action cancellation may also be defined as inhibition of a motor response during the execution 
of such response (Eagle et al., 2008). The commonly used test of response inhibition is the stop-
signal task (SST) (Verbruggen et al., 2008b). A second form of RI is in action 
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restraint/withholding, which captures inhibition of a motor response before a response is 
initiated (Eagle et al., 2008). This feature of RI is measured through the Go/No-Go Task (GNG) 
(Bohne et al., 2008). A third form of RI is called interference control, which refers to 
suppression of interference due to stimulus competition and is commonly measured through the 
Flanker Task (Friedman & Miyake, 2004).  
Note that the taxonomy of functions within RI, as well as the relationship between RI and 
other cognitive and executive functions, are an emerging area in the general literature; while 
some point to the independence of these functions (Khng & Lee, 2014), others state that these RI 
processes are intertwined with other cognitive mechanisms and with each other (Roebers et al, 
2010; Verbruggen et al., 2004). For instance, more complex models of inhibition have been 
proposed revision of the standard horse-race model of RI. For instance, while the strength of go 
and stop processes (and the difference of strength between) may contribute to govern whether a 
ballistic process is inhibited, internal decisional choices, perceptual processing of go and stop 
signals and executive monitoring of success/failure on stop-trials have all been shown to account 
for reaction time on stop trials (Logan et al., 2014). 
The SST, used to measure action cancellation, has been one of the most widely used tasks 
in capturing RI across contexts and disorders (Logan et al., 2014). The SST is a computerized 
measure that presents a series of “go stimuli” (arrows) which subjects respond to with key 
presses. Subjects are instructed that periodically a beep sound (“stop-signal”) will follow the 
presentation of an arrow and in these instances they are to withhold a response. Presentation of a 
stop-signal after go-stimulus comes after a short delay (“stop-signal delay”) that is varied 
dynamically depending on subject performance.  
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The core variable from the SST is a stop-signal reaction time (SSRT). SSRT is calculated 
by subtracting the mean stop-signal delay (SSD), varied according to current performance, from 
subject’s reaction time on no-stop trials (goRT), such that the formula is SSRT = goRT - SSD. 
Figure 1 illustrates the structure of the SST paradigm. Conceptually, SSRT is the finishing time 
of a competition between go and stop processes; it provides an index of the success and 
efficiency of a participant attending to and terminating a motor response already in progress. 
SSRT is reflected in many motor actions that involve competition between go and stop 
processes; imagine, for instance, a baseball player withholding a swing in progress when he/she 
sees a bad pitch. 
The SST has a number of benefits beyond other measures of RI. For one, the SST may be 
able to generate the most descriptive and reliable results from any RI measure because each trial 
can be generated dynamically based on performance (Verburggen & Logan, 2009; Congdon et 
al., 2012). The SST has also been found to be clinically useful for characterizing dysfunction in a 
number disorders, especially in attention-deficit/hyperactivity disorder (ADHD) (Alderson et al., 
2007; Bari & Robbins, 2013; Aron & Poldrack, 2005). Important models have been developed to 
explain SST performance (i.e., race model (Logan et al., 2014)), which allow inference into 
underlying cognitive mechanisms of inhibition. As will be discussed in the following section, 
action cancellation and the SST may be particularly relevant for OCRDs in terms of clinical 
phenomenology. Because of its breadth of explanatory data, empirical support and clinical 
utility, the SST is the central measure of RI in this project.  
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Response Inhibition and OCRDs 
 RI performance in conditions along OCRD spectrum have been the focus of recent 
research in cognitive psychology (Chamberlain et al., 2005). Specifically, RI deficits have been 
found relatively consistently in adults with OCD when compared to control groups (Chamberlain 
et al., 2007a; Penades et al., 2007). Some have found that poor inhibitory control can 
differentiate between those with OCD and other anxiety disorders on a modified GNG task (e.g., 
panic disorder) (Bannon et al., 2008). In addition, those with OCD have been found to have 
different patterns neural of activation (fMRI) on GNG tasks compared to controls (Stern & 
Taylor, 2014). Individuals with OCD and their first degree relatives (FDRs) were compared 
against healthy controls and it was found that both OCD and FDRs groups showed impaired RI 
on the Stroop task (Rajender et al., 2011). A meta-analysis conducted by Leopold & 
Backenstrass (2015) concluded that specific domains within OCD (i.e., checking compulsions) 
may be particularly associated with poor RI control compared to other OC symptoms. 
 RI may be useful in conceptualizing disorders across the OCRD spectrum as well. 
Patterns of poor inhibitory motor control have been observed in TTM as well as OCD (Bohne et 
al., 2008). Chamberlain et al. (2006) found that an OCD and TTM sample both displayed RI 
deficits on SST compared to controls, with the TTM showing worse performance. Grant et al. 
(2011) also found a similar pattern of RI performance in TTM and SPD, with worse performance 
in the SPD sample. Poor RI performance in SPD has been found in additional studies using the 
SST (Odlaug et al., 2010). RI performance in hoarding disorder (HD) has not been researched 
extensively, but Morein-Zamir et al. (2014) found that individuals with HD do not differ in RI 
task performance compared to individuals with OCD and comorbid HD. No work has been done 
using RI paradigms in BDD.   
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On a conceptual level, RI and the notion of impaired inhibitory control is consistent with 
the nature of dysfunction in these disorders; phenomenologically, OCRDs are characterized by 
persistent, repetitive, dystonic thoughts or behaviors that patients often wish they could inhibit 
but cannot (Abramowitz & Jacoby, 2015), and RI is the ability to willfully stop habitual action. 
A frequent report of those with TTM, for instance, is that once a pulling episode has started it is 
difficult to stop. Further, this repeated failure to stop pulling is a core feature of TTM (Jones et 
al., 2010). Where RI is a cognitive function present in everyday life, RI in the OC-Spectrum may 
be a clinical manifestation of a maladaptive cancellation process (Bannon et al., 2008). Some 
have found that this maladaptive stopping process is evident in OCD regardless of whether the 
task involves motor inhibition or thought inhibition (Morein-Zamir et al., 2010). In addition, RI 
dysfunction may be consistent with the underlying neurocircuitry of OCRDs; for instance, it has 
been reported that RI performance correlates with understood biological correlates of OCD (i.e., 
orbitofrontal cortex and right inferior frontal cortex) (Grant & Kim, 2014; Aron et al., 2014). 
Cognitive assessment of OCRDs, especially through RI, may be an important step 
forward scientifically and clinically. OCRDs are heterogeneous in their presentation, so finding a 
common cognitive presentation shared by and unique to OCRDs may aid in clinical 
conceptualization and diagnostic utility. For instance, individuals may have diagnoses that both 
fall in an OCRD class, and they may share genetic influence in how their symptoms present, but 
their overt symptoms may share few similarities. Moreover, common cognitive presentations 
shared between these conditions can help build upon a putative “neurocognitive endophenotype” 
for OCRD conditions (Robbins et al., 2012). In other words, these shared cognitive profiles 
between disorders are thought to provide a bridge between the behaviors we can observe overtly, 
and basic neurobiological and genetic findings (Montague et al., 2012). Some have posited that 
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this specific cognitive ability may be paramount to how we conceptualize dysfunction the OCRD 
spectrum as a failure of top-down inhibitory control (Chamberlain et al., 2005).  
Unknown Factors Regarding Response Inhibition in OCRDs 
 Despite the work that has been done with RI in the OCRD spectrum there are apparent 
discrepancies and problems that need to be addressed. First, it is unclear how reliably and 
consistently RI performance can be measured in OCRDs. Systematic review done by Wright et 
al. (2014) on specific measures of RI (GNG, Connors Continuous Performance Task (CPT), 
Sustained Attention to Response (SART)) illustrate that deficits in inhibitory control are most 
profound in Bipolar Disorder, ADHD and Autism, while OCD shows medium effect sizes for RI 
which are most pronounced in the cognitive capability of cancellation. Conversely, a meta-
analysis of SST performance found a larger effect size for RI in OCD than ADHD (Lipszyc & 
Schachar, 2010). Additionally, Abramovitch et al. (2015) found that RI performance in a GNG 
were impaired in a subclinical analogue sample when compared to controls, suggesting that these 
difficulties with RI are present and related to OC-symptoms regardless of clinical diagnosis; this 
finding is consistent with the idea of RI as a potential endophenotype of OCRDs. In contrast, 
multiple studies have not found any difference in RI performance between OCD and controls 
(Tolin et al., 2014; Blom et al., 2011). Thomas et al. (2014) found no difference between panic 
disorder and OCD in GNG performance and also found similar patterns of electroencephalogram 
(EEG) activation in these two disorders when compared against healthy controls. Stern & Taylor 
(2014) suggest that RI tasks are themselves confounded by mechanisms that are impaired in 
OCD, such as performance monitoring, which may result in falsely attributing RI deficits as core 
to OC-symptomology.  
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 Second, it has been posited that RI performance in OCRDs can be better accounted for by 
comorbid depression. Depression is a multifaceted condition that is also accompanied by a host 
of cognitive deficits (McIntyre et al., 2013; Austin et al., 2001; Harvey, 2007). These deficits in 
depression may also be associated with tangential features necessary for effective SST 
performance, namely executive functioning processes such as working memory and planning 
ability. Some have suggested that OCD is accompanied by a set of unique cognitive functioning 
deficits that are independent of depression (Aycicegi et al., 2003), and that the difficulties in 
depression do not necessarily overlap with those in OCD (Vergara-Lopez et al., 2013). Others, 
however, posit that both OCD and depression share deficits in selective attention, and suggest 
that this process is key to RI performance in both conditions (Koch & Exner, 2015). 
 The potential influence of comorbid depression on RI performance in OCRDS may be 
particularly troubling for at least two reasons. First, depression has also been found to have a 
moderate degree of difficulty in inhibitory control (Lau et al., 2007; Schulz et al., 2007). There is 
a growing body of literature suggesting that poor inhibitory control in depression may be 
particularly accentuated when stimuli in RI measures are emotionally relevant (Albert et al., 
2010). It may be the case that the emotional quality of stimuli themselves, specifically in their 
degree of eliciting arousal, may affect RI performance (De Houwer & Tibboel, 2010; 
Verbruggen & De Houwer, 2007). Some have found that individuals with Major Depressive 
Disorder (MDD) have slower reaction time generally than controls, which may in turn affect RI 
performance (Schlosser et al., 2013). With specific regards to the SST, slow reaction time may 
lead to a distorted SSRT; because go-reaction time is a critical component of calculating SSRT, a 
systematic slowing of response time can muddle the value of this RI index. Dillon et al. (2015) 
suggest that mood related aspects of depression, such as anhedonia, may also affect RI 
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performance. Interestingly, the presence of comorbid depression seems to affect RI performance 
in other disorders besides OCD, such as alcohol dependence (Jakubczyk et al., 2012). 
Second, depression is a common comorbidity of OCD. A breadth of data suggests that 
depression is the most common comorbidity in OCD (Pallanti et al., 2011), and is ten times more 
prevalent in OCD patients than in the general population (Denys et al., 2004). Pallanti et al. 
(2011) suggest that between 60-80% of individuals with OCD will experience at least one major 
depressive episode in their lifetime. Further, these comorbid depressive features can have 
important implications for treatment response (Torp et al., 2015). While comorbid depression 
does not necessarily produce more severe OC-symptoms, such OC-symptoms are a significant 
predictor of depression (Yap et al., 2012). Thus, if depression may account for a modicum of 
poor RI performance, and depression is highly comorbid with OCD, then our current 
understanding of RI in OCRDs may be inaccurate in not having factored out the influence of 
cognitive and executive functioning deficits associated with depression. The problem then 
becomes: how can one be sure that RI performance in OCRD are truly related to their core 
symptomologies and not their comorbidities? 
There are additional dimensions of psychopathology that may be important in 
interpreting RI performance in OCRDs. First, the relationship between trait impulsivity and RI 
may be an important one. Many disorders characterized by impulsivity, such as attention-deficit 
hyperactivity disorder (ADHD), show marked impairments on the same measures of RI and 
interference control (van Velzen et al., 2014; Sjoerds et al., 2014). Disorders characterized by 
dysfunctional impulse control, such as pathological gambling (PG), may also show impaired RI 
(Grant & Kim, 2014). Additionally, individuals affected by ADHD and OCRDs demonstrate a 
similar pattern of neural activation during SST, namely reduced inhibition-related activation of 
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the caudate nucleus, inferior frontal gyrus (IFG) and supplementary motor area (SMA) (van 
Velzen et al., 2014). The fact that RI tasks show similar performance in disorders of 
compulsivity (i.e. OCRDs) and impulsivity (i.e., ADHD, PG) can imply a number of things, such 
as a putative relationship between these symptom dimensions (Robbins et al., 2012; Berlin & 
Hollander, 2013) or something else entirely. The current state of the literature, however, does not 
address how RI functions within broad domains of compulsivity and impulsivity and more work 
is needed to clarify its standing. 
Second, “not just rightness,” or incompleteness, may be and important variable related to 
OCRD symptomology and RI. Not just right experiences (NJREs) refer to a mismatch between a 
perceived current affective state compared to a desired state of experiences (Fergus, 2014), or, an 
“irremediable sense that one’s actions or experiences are not ‘just right’” (Summerfeldt, 2004). 
These experiences have recently emerged in the literature as an important symptom domain 
within OCRDs (Coles et al., 2005), and challenge the conception that OC-symptomology is 
driven solely by harm avoidance (Taylor et al., 2014). One study analyzed incompleteness in 
OCRDs and compared them against other conditions (PG and eating disorders) and concluded 
that this domain was specific to OCRD symptomology (Sica et al., 2015). Incompleteness may 
be related to RI as a motivational factor; incompleteness may drive someone to complete a task 
to fullness, and this difficulty stopping a behavior prior to the point of “just-rightness” could be 
either a cause or reflection of RI (Ecker & Gönner, 2008). This area of research is quite new and 
there is a paucity of data regarding how NJREs fit together with cognitive functioning in OCRDs 
and RI. However, given the potential importance of both RI and incompleteness in OCRD 
symptoms, it is critical to see how these variables are related. 
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Lastly, it is unknown whether RI performance is a clinically useful indicator in 
conceptualizing patient disability. No research exists that studies the relationship between RI and 
quality of life (QoL) or overall disability. OCD itself has been characterized by both functional 
impairment and reductions in QoL when compared with healthy controls (Huppert et al., 2009). 
Some have posited that two factors within OCD are main contributors to life distress: obsessional 
severity and comorbid depressive symptomology (Masellis et al., 2003). Some suggest that 
different levels of impairment and relapse rates depend on different obsessional content (Eisen et 
al., 2013; Matsunaga, 2013). However, the active ingredient within OCD that leads to general 
life impairment is still unclear. Work needs to be done to analyze how specific symptom 
domains and relevant cognitive deficits may contribute to QoL and disability among OCRDs. 
Study Aims and Hypotheses  
The aim of this project was to parse out the influence of comorbid psychopathology on 
RI performance in OCRDs. To this end, we utilized data from an ongoing clinical trial to 
examine RI performance in OCD and TTM along with symptoms of depression. Primarily, we 
hypothesized that RI performance would be better explained by symptoms of OCRDs than by 
symptoms of comorbid depression. Specifically, we predicted that variance in the core measure 
of RI in the SST would be better accounted for by OCRD symptomology than by symptoms of 
comorbid depression. 
 We were also interested in probing how underlying, OC-related traits were related to RI 
performance. Specifically, we sought to investigate how domains of impulsivity and 
incompleteness related to SST performance in OCD and TTM. As literature in these area are not 
developed well, we explored whether the magnitude of impulsivity and incompleteness would be 
statistically related to the SST indices that reflect core RI. Additionally, we aimed to study how 
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overall life disability is associated with RI in OCD and TTM. Again, though no data are 
available to suggest a directional relationship between these two factors, we expected that the 
magnitude of SSRT would increase in tandem with difficulties in QoL. 
Methods 
Participants 
For the current study, participants were considered for eligibility assessment if they were 
ages 18-60, were actively symptomatic for OCD or TTM, did not report or evidence any severe 
psychopathology on a phone screening (i.e., bipolar disorder, substance use disorders, 
schizophrenia, suicidality, etc.), and were not in current cognitive-behavioral therapy for OCRDs 
(i.e., exposure and response prevention, habit reversal therapy).  
Sixty-one individuals were assessed at the main study visit for this project, but 49 
individuals were included in the final analysis. Seven individuals were excluded because they 
were assessed prior to the inception of this masters project, thus they did not receive the full 
assessment battery with measures of depression. Additionally, 5 individuals were excluded for 
reasons of either not having OCD or TTM, or presenting with a cognitive complaint that made 
assessment with SST invalid. 
The mean age of participants was 29.59 (SD = 10.80). There was a gender preponderance 
for females (female = 67.3%, n = 33; male = 32.7 %; n = 16). The sample was largely Caucasian 
but showed some variance in race: Caucasian = 81.6% (n = 40), African-American = 10.2% (n = 
5), Two or more races = 6.1% (n = 3). For ethnicity, 2% (n = 1) of our sample identified as 
Hispanic/Latino.  The mean WASI FSIQ-2 score for our sample was 105.04 (SD = 10.45). These 
and additional demographic characteristics are presented in Table 1.  
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Fifty-five percent of our sample had only OCD as an OCRD diagnosis (n = 27), 26.5% of 
our sample had only TTM as an OCRD diagnosis (n = 13), 6.1% of our sample had primary 
OCD with secondary TTM (i.e., OCD+TTM, n = 3) and 12.2% had primarily TTM with 
secondary OCD (i.e., TTM+OCD, n = 6). Those with dual diagnoses were grouped together for 
analyses due to a small individual sample. Our final analytic groups were as follows: OCD only 
(n = 27), TTM only (n = 13) and Combined diagnoses (n = 9). 
In terms of comorbidities, 42.9% (n = 21) individuals met criteria for current major 
depressive disorder (i.e., MDD-current depressive episode), and 8.2% (n = 4) for persistent 
depressive disorder (PDD). For other comorbidities, from most to least frequently diagnosed, 
57.1% (n = 28) met criteria for generalized anxiety disorder (GAD), 44.9% (n = 22) for social 
anxiety disorder, 18.4% (n = 9) for post-traumatic stress disorder (PTSD), 16.3% (n = 8) for a 
specific phobia, 14.3% (n = 7) for ADHD, 8.2% (n = 4) for agoraphobia, 6.1% (n = 3) 
individuals for panic disorder, 6.1% (n = 3) for separation anxiety disorder, 6.1% (n = 3) for 
body dysmorphic disorder (BDD), 6.1% (n = 3) for substance use disorder (SUD),  6.1% (n = 3) 
who reported diagnoses on domains not assessed (i.e., dermatillomania), 4.1% (n = 2) for 
bulimia nervosa, 2% (n = 1) for illness anxiety disorder, and 2% (n = 1) for alcohol use disorder. 
Chi-square analyses showed significant group differences in rates of diagnosis for separation 
anxiety, PTSD and SUD. No group differences were found on other demographic variables or 
diagnostic status. 
Data collection procedures 
 Data were collected as part of a clinical trial testing the effectiveness of RI training in 
OCD and TTM. Specifically, data for this project were collected as part of an on-site “full 
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eligibility assessment,” which took place following online and phone-based pre-screen 
procedures and prior to baseline and randomization.  
Prior to eligibility assessment, individuals interested in the project contacted study staff 
and completed self-report measures of illness severity (Obsessive-Compulsive Inventory Revised 
(OCI-R) (Wootton et al., 2015); Massachusetts General Hospital Hairpulling Scale (MGH) 
(Keuthen et al., 2007). Subjects who scored above a certain threshold (OCI-R ≥ 21 or MGH ≥ 
12) were contacted for assessment of exclusion criteria by phone to ensure that we were 
identifying an actively symptomatic sample (Monzani et al., 2014; Stein et al., 2010). Individuals 
were screened to ensure that they were ages 18-60, were not currently experiencing mania, 
psychosis, alcohol use or substance use disorder. Though not specifically assessed, participants 
were excluded if they reported suicidality. Individuals were also assessed to ensure the presence 
of OCD or TTM on the Mini International Neuropsychiatric Interview 6.0 (MINI-6.0) OCD 
module and TDI. Participants who met these criteria were invited to the University of 
Wisconsin-Milwaukee for a single-session eligibility assessment for the larger clinical trial to 
which they were interested in. Note, however, that information endorsed/not endorsed on phone 
screening was not truly confirmed until on-site screening; subjects over/underreported symptoms 
on the phone which led to a heterogeneous clinical sample in this project. Actual subject 
characteristics included those who would not meet criteria for the main clinical trial.  
Measures 
All measures given for this project were administered in a single session at the University 
of Wisconsin-Milwaukee. At the study visit where data was collected, participants were assessed 
for general diagnostic status (Anxiety Disorders Interview Schedule for DSM-5 [ADIS-5]), 
OCRD diagnostic status and symptom severity (Trichotillomania Diagnostic Inventory [TDI]; 
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self-report versions of the Yale-Brown Obsessive-Compulsive Scale [Y-BOCS]; MGH), and RI 
(SST). Additional self-report measures for our exploratory aims were given at this eligibility 
session as well. A full list of measures used for this project are provided in Table 2. All self-
report measures excluding BDI-II were given via Qualtrics on-site in the laboratory. The BDI-II 
was given on paper. A detailed description of measures follows: 
Anxiety Disorders Interview Schedule for DSM-5 Disorders (ADIS-5) (Brown &  
Barlow, 2013). The ADIS-5 is a structured clinical interview designed to assess and 
diagnose DSM-5 disorders (i.e., depression, anxiety, trauma, OCRDs and SUDs).  
Self-Report Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) (Federici et al., 
2010). The YBOCS is the gold-standard assessment tool for OC-symptoms. The 
instrument uses a checklist of current OCD symptoms, and uses these symptoms as a 
reference for a 10-item severity score. The self-report version has been shown to have 
good convergence with the clinician-rated version, though clients may underreport 
symptoms on the self-report version. 
Massachusetts General Hairpulling Scale (MGH) (Keuthen et al., 2007). The MGH is 
a 7-item brief self-report measure of hair pulling that measures urges, active pulling time, 
perceived control and associated distress. 
Beck Depression Inventory-II (BDI-II) (Beck et al., 1996). The BDI-II is a 21-item 
self-report questionnaire that measures major domains of depression symptomology (i.e., 
cognitive, mood, and somatic symptoms as well as suicidality). Items on the BDI-II range 
from 0-3 and a total score is calculated by summing all 21 items. Scores from the BDI-II 
can produce both continuous measures of depression (i.e., scores from 0-63) and 
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categorical cut-off scores (i.e., “moderate depression” as scores from 20-28) (Yap et al., 
2012). The BDI-II, as used in this project, was mainly for assessment of suicidality. 
Depression Anxiety Stress Scale (DASS) (Lovibond & Lovibond, 1995). The DASS is a 
42-item self-report scale that probes three domains: Depression (subscales assess mood 
components), anxiety (somatic symptoms and subjective experience), and stress (levels of 
non-chronic arousal). Questions are in a four-point likert format ranging from 0 (“did not 
apply to me at all”) to 4 (“applied to me very much, or most of the time”).  
Barratt Impulsiveness Scale-11 (BIS-11) (Patton et al., 1995). The BIS-11 is a 30-item 
self-report questionnaire that probes domains of attentional, motoric, cognitive, inhibitory 
and perseverance impulsivity and is one of the most widely used measures of impulsivity. 
The BIS-11 produces a total score as well as scores for six first-order factors and three 
second-order factors.  
Obsessive-Compulsive Trait Core Dimensions Questionnaire (OC-TCDQ) 
(Summerfeldt et al., 2001). The OC-TCDQ is a 20-item self-report measure that assesses 
core dimensions of OCD in regards to harm avoidance and incompleteness. Items are in a 
likert format (0= “Never applies to me, 4= “Always applies to me”). The questionnaire 
produces a two-factor structure (harm avoidance and incompleteness). Both subscales in 
this measure have shown strong internal consistency in nonclinical samples (Coles et al., 
2005). 
Sheehan Disability Scale (SDS) (Sheehan et al, 1996). The SDS is a widely used 
questionnaire that utilizes three self-reported items to measure impairment in 
occupational, social, familial/home function. Each item is rated on a 0 (“not at all”) to 10 
(“very severely”) scale. Items on this scale are accompanied by visual anchors (i.e., 
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mildly, moderately, markedly). The SDS has been widely used to assess disability as a 
result of symptoms in primary care and treatment outcome research.  
Wechsler Abbreviated Scale of Intelligence (WASI-II) (Wechsler & Hsiao-pin, 2011). 
The WASI-II is an abbreviated measure of overall cognitive and intellectual functioning 
appropriate for individuals ages 6 to 90. Individual subtests of vocabulary and matrix 
reasoning were administered to get a short index of overall cognitive functioning. 
Cognitive Assessment 
 Response inhibition performance was measured via the SST (Logan, 1994). The task is 
computerized and administered through Inquisit software (Verbruggen et al., 2008b). Subjects 
underwent one practice block with 32 trials and three testing blocks with 64 trials each. Stop-
signals occurred randomly on 33% percent of trials such that there was a 3:1 ratio of no-stop-
signals to stop-signal trials within each block. The stop-signal delay (SSD) was varied depending 
on subject performance (lengthened or shortened) such that the probability of a participant 
responding correctly to any given stop-signal trial was approximately 50%. This SSD was 
initially set at 250ms and adjusted up or down by 50ms depending on performance (max = 
1150ms, min = 50ms). Data was recorded for response time, omission and commission errors, 
mean stop-signal delayed and probability of response for stop-signals. Stop-signal reaction time 
(SSRT) is the core measure of RI in this paradigm and was calculated by the software by 
averaging mean reaction times on ‘go’ trials without a stop-signal and subtracting the mean SSD 
(i.e., SSRT = goRT – SSD) (Chamberlain et al., 2007a; Verbruggen & Logan, 2009). 
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Results 
Symptom Profile 
 A detailed description of symptom scores is provided in Table 3. Mean YBOCS scores 
for those who had only OCD as an OCRD diagnosis was 22.81 (SD = 5.27), and mean MGH 
scores for those with TTM as an only OCRD diagnosis were 17.07 (SD = 4.42). For those with 
both OCD and TTM, mean total YBOCS scores were 22.00 (SD = 4.66) and mean MGH scores 
were 18.11 (SD = 5.13). Mean SSRT for the whole sample was 223.71 (SD = 43.91) and the 
mean DASS-Depression (DASS-D) subscale was 12.57 (SD = 10.94; Score Descriptor = Mild 
Depression). 
 A one-way ANOVA was conducted to detect differences between diagnostic groups on 
the measures administered. No significant differences were found between groups on critical 
measures of depression, SSRT, SSD or goRT. We found significant differences between groups 
on measures of anxiety (F(2, 46) = 3.24), p < 0.05), attentional impulsivity (F(2, 46) = 5.01, p < 
0.05), harm avoidance (F(2, 46) = 11.70, p < 0.001) and incompleteness (F(2, 46) = 12.62, p < 
0.001). Post-hoc analysis with a Scheffé test of significance showed that the OCD and mixed 
group were elevated compared to the TTM ground on incompleteness, and the OCD group was 
elevated on anxiety, harm avoidance, and attentional impulsivity compared to the TTM group. 
This suggests that even though core variables of interest are comparable across groups, certain 
dimensional measures (i.e., anxiety) may need to be added as a covariate in statistical analysis in 
explaining SSRT. 
Preliminary Analyses 
 Prior to testing our main hypothesis, we implemented two preliminary procedures. First, 
z-transformation was applied to OCRD symptom indices (i.e., YBOCS and MGH scores) in both 
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OCD and TTM groups. Thus, among those with OCD as a primary diagnosis, z-transformation 
took total YBOCS Scores for each participant, subtracted the mean score for the OCD group and 
divided that value by the standard deviation of the group ((YBOCS Score – M)/SD [m=0, 
SD=1]). In those with TTM as a primary diagnosis, z-score transformation followed the same 
procedure and instead used MGH scores ((MGH Score-M)/SD [m=0, SD=1]). These z-scores 
were consolidated together into a uniform ‘OCRD z-score’ to be entered as one variable to 
signify overall OCRD severity. This was to ensure that symptom scores could be analyzed 
together across the two conditions regardless of actual diagnostic status. 
 Second, a series of bivariate correlations were conducted to get a broad understanding of 
how critical variables of depression, OCD and TTM symptoms, and SST variables related to 
each other both within and between diagnostic groups. SST variables (i.e., SSRT, SSD, etc.) and 
symptom severity indices (i.e., OCRD z-scores, YBOCS, MGH) were entered into this 
correlation. Analysis was performed for the whole sample (i.e., RDoC approach) and across 
diagnostic groups to catch potentially important group differences. Results are presented in 
Tables 4 and 5. 
 Across the whole sample, SSRT was not significantly related to depression. However, 
SSRT was also not significantly related to the z-centered OCRD symptom scores. In fact, none 
of the seven indices from the SST were significantly related to OCRD severity or either measure 
of depression. There was a trending pattern of significance to suggest that depression severity 
was negatively associated with SSRT (i.e., less depression, longer SSRT). Moreover, depression 
showed a trending positive pattern with goRT and SSD.  
 The same variables were entered into a correlation, but data were split so the analyses 
were conducted for those with only OCD or TTM as an OCRD diagnosis. Amongst those with 
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OCD, neither YBOCS total scores nor obsessional severity were significantly related to SSRT. 
However, compulsion severity was significantly associated with SSRT (r(26) = .433, p = 0.027) 
whereas depression scores were not. The relationship between YBOCS compulsion scores and 
SSRT are reflected in a scatterplot in Figure 2. Though it did not reach significance level, 
YBOCS total scores were trending towards a pattern that suggest that worse OC-severity, 
especially amongst obsessional severity, is associated with lower percentage of correct responses 
on go trials (r(26) = -.340, p = 0.09).  
 Amongst those with TTM, hair pulling severity was not significantly related to SSRT, 
nor was SSRT significantly related to measures of depression. This comes in contrast to the OCD 
group, where compulsion severity was correlated with SSRT. Hair pulling severity was 
approaching significance levels with commission reaction time, overall go-trial reaction time and 
percentage of omissions. Due to small sample size (n = 9), the mixed diagnosis group analysis is 
not included here.  
 Results of these correlations suggest that SSRT may have a more specific relationship 
with symptom severity when considering an OCRD diagnosis. More specifically, these 
correlations suggest that certain symptoms may be more relevant to SSRT (i.e., compulsions vs. 
obsessions). Thus, we utilized dummy coding with hierarchical regression to quantitatively 
examine any differential patterns of OC-Symptom—RI performance association depending on 
primary diagnosis (OCD, TTM, or mixed diagnosis). Our two dummy coded variables 
represented three groups: OCD (reference group), TTM, and OCD with TTM (mixed diagnosis); 
D1 = OCD vs. TTM and D2 = OCD vs. Mixed Diagnosis. SSRT was the DV being predicted in 
this regression. In Step 1, we added the following variables to get a broad overview of how 
covariates would be accounting for RI performance: gender, DASS depression, stress and 
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anxiety scores. Depression, stress and anxiety scores were centered around their respective grand 
means to reduce potential multicollinearity issues. In Step 2, we added the two dummy coded 
variables (i.e., D1 = OCD vs. TTM, D2 = OCD vs. Mixed) and the z-centered OCRD scores. 
Lastly in Step 3, we added interaction scores for OCD vs. TTM and OCD vs. Mixed Diagnosis. 
Results are presented in Table 6.  
There was a marginally significant interaction between the OCD vs. TTM status and the 
severity of OCRD symptoms in predicting SSRT ( = -.328, t = -1.996, p = 0.53). Additionally, 
there was a significant interaction between the OCD vs. mixed diagnosis status and the severity 
of OCRD symptoms in predicting SSRT ( = -.515, t = -3.025, p = 0.004). This interaction is 
illustrated in Figure 2. These findings suggest that there is some merit to looking beyond our 
sample in aggregate. Thus, for our subsequent analyses we use both our whole sample and 
specific diagnostic subgroups to explore important differences. 
Primary Analyses 
 The central question of this project is whether RI performance, as defined by SSRT, is 
better accounted for by OCRD symptomology or by comorbid depressive symptoms. Our 
primary hypothesis was that among individuals diagnosed with OCRDs, the severity of OCRD 
symptoms would significantly predict RI even when comorbid depression was accounted for.  
To test our main hypothesis, we utilized hierarchical linear regression. In this analysis, 
SSRT scores were entered as a dependent variable. In Step 1, DASS depression, anxiety and 
stress and gender were entered to produce a model to estimate the variance in SSRT accounted 
for by Step 1 variables (i.e., R2). Anxiety and stress were added because they are common 
covariates of depression. Gender was added as a covariate because (a) there was a gender 
preponderance of females in our sample, and (b) depression has been linked generally to a higher 
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incidence in women. In Step 2, OCRD z-scores were entered to examine the R2 change, or, to see 
the additional variance in SSRT that was significantly explained by OCRD symptoms even after 
for controlling for additional factors of depression, anxiety, stress and gender. Results of this and 
the following regression analyses are presented in Table 7.  
 Step 1 variables accounted for approximately 11.7% of the variance in SSRT, however 
this was not statistically significant (R2 = .117, F(4, 43) = 1.425, p > 0.05). Adding OCRD z-
scores in Step 2 only explained approximately 0.3% of the additional variance in SSRT (R2  ∆ 
= .003, F(5, 42) = 1.51, p > 0.05;  = .063, t = .406, p = .687).  
 Based on the results of earlier correlational analyses, it was thought that SSRT values 
may be affected by the diagnostic status. Thus, we utilized regression and divided our sample 
based on whether participants had OCD, TTM or combined OCD+TTM. So, for our first sub-
group analysis cases were selected if participants had only OCD (i.e., no TTM or OCD + TTM 
cases). We entered depression, anxiety and stress scores and gender in Step 1 of the regression 
and used non-z-centered YBOCS total scores as a predictor variable in Step 2. Here, Step 1 
variables accounted for about 18.5% of the variance in SSRT (R2 =.185, F(4, 21) = 1.191, p = 
.344), but when adding YBOCS total scores approximately 11.2% additional variance was 
explained in SSRT (R2 Δ =.112, F(5, 20) = 1.686, p = .184). Specifically within this model, 
YBOCS total scores were the best predictor of SSRT values and were approaching statistical 
significance ( = .365, t = 1.782, p = .090). This analysis was repeated but instead of YBOCS 
total scores being entered in Step 2, YBOCS subscales of obsession and compulsion severity 
were entered together. Here, OCD symptoms accounted for an additional 20% of variance in 
SSRT scores (R2 Δ =.207, F(6, 19) = 2.043, p = .109) and though obsessional severity was not a 
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predictor of  SSRT ( = -.027, t = -.175, p = .863), compulsion severity was the only significant 
predictor of RI ( = .473, t = 2.473, p = .023).  
 These analyses were conducted in the same fashion with the TTM subsample. Gender, 
depression, anxiety and stress scores were entered in Step 1 of the regression and MGH total 
scores in Step 2. MGH scores here explained about 12.7% of the additional variance in SSRT 
which was non-significant (R2 Δ =.127, F(5, 7) = 1.230, p = .387;  = -.403, t = -1.291, p = .238). 
Within this model, the only variable approaching significance as a predictor was general stress ( 
= -.882, t = -2.039, p = .081).   
 Lastly, we computed regression using cases with mixed diagnoses using the z-centered 
OCRD symptom scores as a Step 2 variable. OCRD severity in this mixed group only accounted 
for approximately 1.3% in the additional variance in SSRT and this was not statistically 
significant (R2 Δ =.013, F(5, 3) = .622, p = .701;  = -.189, t = -.283, p = .796).  
 Taken together, our primary hypothesis that SSRT symptoms would be better accounted 
for by OCRD symptoms than by depression was only found in the OCD group, and not for those 
presenting with TTM or dual-diagnoses of OCD+TTM. Further, within those with OCD, 
compulsion severity was the best (and only) significant predictor of SSRT. Depression was not a 
significant predictor of SSRT in any model, but amongst those with TTM general stress was a 
variable that was approaching significance as a predictor of SSRT. 
Secondary Analyses 
An exploratory aim of this project was to evaluate the relationship between SSRT and 
associated symptom factors of OCRDs such as impulsivity [BIS-11], incompleteness [OC-
TCDQ], and life disability [SDS]. Additionally, we were interested to see how these associated 
factors were related to core OC-symptomology. We expected to see that SSRT would increase 
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commensurate with levels of life impairment, impulsivity (particularly in terms of motor 
impulsivity) and harm avoidance/incompleteness. Additionally, we expected that those with 
higher OC-symptoms may have higher levels of life impairment. 
To explore these relationships we utilized bivariate correlation. Analyses were conducted 
with the aggregate sample and by diagnostic subgroups of OCD and TTM (note: the mixed 
diagnostic group was not included due to small sample size (n = 9)). To generate a correlational 
matrix we entered z-transformed indices of symptom severity, SST variables, BIS sub-scale 
scores of attentional, motor and non-planning impulsivity, OC-TCDQ harm avoidance and 
incompleteness scores, SDS scores for global functioning impairment, and DASS anxiety, 
depression and stress subscale scores. For subgroup analyses, OCRD scores were substituted 
with either YBOCS (total, obsession and compulsion) or MGH total scores depending on the 
diagnostic group. We were interested primarily in how associated features of OCRDs related to 
(a) core OCRD symptoms via YBOCS, MGH and z-centered scores and (b) SSRT (Tables 8 & 
9).  
In the aggregate sample no features of impulsivity were significantly related to SSRT or 
OCRD severity. This was also the case for overall life impairment, in that neither SSRT nor 
OCRD severity showed a significant relationship. Neither harm avoidance nor incompleteness 
were significantly related to SSRT, and they were not significantly associated with overall 
OCRD severity. Taken together, none of our hypotheses that SSRT would be related to OC-
associated factors were confirmed. Additionally, none of these associated factors were related to 
OCRD severity.  
 In the OCD group, again SSRT was not significantly related with any of the OC-
associated of impulsivity, harm avoidance/incompleteness or overall life disability. Additionally, 
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these factors were not significantly related to core OCD symptomology of obsessions, 
compulsions or total OCD severity. The only factors that were related to core OCD symptoms 
were harm avoidance and incompleteness, but these factors are themselves an emerging 
component of OCD.  
In the TTM group, a similar null pattern emerged in that SSRT was not significantly 
related to the exploratory associated features. However, non-planning impulsivity was negatively 
related to hair pulling severity (r(13) = -.649, p = .016), suggesting that those who are more 
impulsive in this domain actually have less severe TTM. 
In sum, the variables chosen as exploratory measures due to their potential relatedness to 
OCRDs were largely unrelated to SSRT. Additionally, these factors were unrelated to core 
OCRD symptomology of OCD and TTM except in one domain which was non-planning 
impulsivity, and only for those with TTM. These finding suggest that SST and the indices from 
the BIS-11, OC-TCDQ and SDS are measurements of unrelated symptom factors, and their 
relationships do not differ as a product of specific OCRD diagnosis.  
Results from regression demonstrated that SSRT was most related to compulsional 
aspects of OCD. Thus, we were interested to see which specific features of compulsions and 
compulsive behavior in OCD and TTM were contributing to SSRT. Thus, we entered specific 
items from the YBOCS and MGH (depending on diagnostic group) into a bivariate correlation 
with SST variables to see how SSRT was related to specific features of each disorder. Results are 
presented in Tables 10 and 11.  
In the OCD group, interference of compulsions (YBOCS item #7) and distress from 
compulsion prevention (YBOCS item #8) were both significantly related to SSRT. In the TTM 
group, however, no individual items were associated with SSRT. Rather, the significant relations 
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among individual items in those with TTM were from MGH items and extraneous SST variables 
such as reaction times. The lack of significant relation between SSRT and individual hair pulling 
symptoms may help to explain null findings earlier in our regression analysis.  
Discussion  
 Cognitive faculties among OCRDs have become the focus of recent research. 
Particularly, RI has emerged as a potentially useful marker in capturing symptomology unique to 
the OCRD spectrum. A growing line of research goes so far as to suggest that RI and the notion 
of impaired inhibitory control may be useful as a putative endophenotype of OCRDs 
(Chamberlain & Menzies, 2009; Robbins et al., 2012).  
However, despite the growing interest in RI among OCRDs there a number of points that 
require critical clarification. Most importantly, the influence of comorbid psychopathology, 
notably of depression, needs to be accounted for in explaining RI performance. Additionally, 
similarities and differences in RI performance across different OCRDs need to be established 
and replicated. Lastly, the current state of the literature does not suggest how RI is related to 
other symptom domains that may be relevant for OCRDs such as impulsivity, incompleteness 
and life disability.  
To explore these questions, we utilized a community sample of individuals with OCD 
and TTM. Individuals were assessed as part of an eligibility assessment for a clinical trial testing 
RI training. Participants were assessed with a battery for diagnostic status, symptom severity, RI 
performance, as well as depression, anxiety, impulsivity, incompleteness and life disability. Data 
were subjected to a series of hierarchical multiple regression analyses and bivariate correlations. 
Our primary hypothesis that OCRD severity, understood as symptom severity across 
multiple diagnoses on the obsessive-compulsive spectrum, would predict RI performance above 
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and beyond depression was not supported for the overall OCRD symptoms included in this 
study; even before controlling for the influence of depression, combined symptoms of OCD and 
TTM were not predictive of RI. 
However, we found a significant group-by-symptom severity interaction in predicting the 
SSRT index. Particularly, in the OCD group, compulsion severity was a significant predictor of 
inhibitory control whereas obsessions and total OCD severity were not. This finding was robust 
even when controlling for depression and depression related covariates of stress and anxiety. 
Meanwhile in the trichotillomania group, there was no relationship between RI and pulling 
symptoms. In mixed sample of those with both OCD and hair pulling, overall symptom scores 
were not predictive of inhibitory control. Though the SSRT values we found were comparable to 
other findings in previous studies (Chamberlain et al., 2006: OCD SSRT = 211.6, TTM SSRT = 
264.9), we did not find that those with TTM had longer SSRTs than those with OCD. 
Additionally, we were unable to replicate the findings that those with worse hair-pulling severity 
had more difficulty in RI, and we found that SSRT was related to compulsion severity, which it 
was not in this previous study (Chamberlain et al., 2006). The SSRT values we found, compared 
to those of the healthy controls reported in Chamberlain et al. (2006) [SSRT = 167.8], were 
substantially elevated, however; comparison of these data reinforce the notion that SSRT in 
OCRDS (both in OCD and TTM) are elevated compared to healthy populations.  
Thus, our primary hypothesis was supported only for a subgroup of individuals with 
OCD, and not for those with symptoms of TTM. The relationship we found suggests that those 
with greater compulsional severity have worse RI performance, and meanwhile worse 
obsessional severity has little influence in RI performance. These data relate to earlier meta-
analytic suggest that deficiencies in RI may themselves pose as a vulnerability for compulsional 
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severity, but not for obsessional pathology in the context of OCD symptoms (Leopold & 
Backenstrass, 2015). Moreover, our data corroborate these meta-analytic findings that RI may 
have particular utility in exploring the hallmark compulsions of OCD. Phenomenologically, the 
linkage between compulsions and RI as defined by SST performance are meaningful; the SST is 
a measurement of motor inhibition, or, stopping actions that are no longer necessary 
(Verbruggen & Logan, 2009).  
The relationship between RI capabilities and compulsion severity was found when 
factoring out the influence of depression and its covariates, suggesting that depression actually 
has very little influence in generating RI deficits. There are theoretical reasons to suspect that 
depression may be an insidious comorbidity in accounting for cognitive performance across 
disorders; facets of impaired inhibitory control (Lau et al., 2007), slow reaction time on cognitive 
tasks generally (Schlosser et al., 2013) and strong underlying anhedonia (Dillon et al., 2015) can 
all theoretically contribute to what looks like difficulty in stopping an inappropriate response. 
Despite these suggestions, however, the relationship between depressive symptoms and RI were 
not robust especially when compared to the influence of compulsions on explaining RI.  
Our data suggest that depression was negatively correlated with the SSRT (-.30 for the 
OCD and -.67 for the Trich group). Depressive symptoms showed non-significant but 
numerically positive correlation coefficients with goRT and SSD. This suggests that the level of 
depression may be linked to slowed reaction time, and increased success in stopping, which may 
have resulted in the negative association between depression and SSRT. Thus, in the current 
sample, the comorbid depressive symptoms may have attenuated the manifestation of RI deficits. 
From this consideration, the finding that compulsional severity is a significant predictor of SSRT 
even after controlling for depressive symptoms is quite robust. 
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We also explored the relationship between OCRD symptoms, RI and a number of 
symptom clusters that are secondarily related to OCRDs such as impulsivity, harm avoidance, 
incompleteness, and overall life disability as a result of psychiatric illness. Across the whole 
sample, and by diagnostic group, SSRT was not related to any of these associative measures. In 
other words, factors of impulsivity, harm avoidance, incompleteness or life distress are not 
reflected in SSRT in either OCD or TTM. Additionally, these variables were largely 
unassociated with core OC-symptoms of obsessions, compulsions and hair pulling. An exception 
was found in a significant relationship between non-planning impulsivity and hair pulling 
severity.  
Findings from these secondary analyses suggest that RI is a cognitive process that is 
distinguished from what is measured on other scales of impulsivity, and that RI capabilities do 
not necessarily proscribe information about life distress or associated OC-factors of 
incompleteness or harm avoidance. More specifically, wheras impulsivity is typically understood 
a broad, higher order and affectively laden construct, RI, as defined and measured by the SST 
paradigm, may be conceptualized more precisely as a cognitive process, removed from more 
affective contexts, involved in initiation and execution of motor responses. One additional 
consideration is that a lack of association between RI and additional measures may have come 
from a difference in mode of assessment (i.e., cognitive vs. self-report measures); considering 
the potential influence of measurement type, the link between SSRT and compulsion severity 
may be quite meaningful.  
So, the broad pattern of results suggest that SSRT is differentially important in capturing 
OC-symptoms in that disorder-specific compulsive behavior may be more important in 
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explaining RI. In other words, the pattern of OCRD symptom-RI performance association was 
observed only for OCD but not for TTM, and also not for combined OCD-TTM.  
There are a number of possibilities that may explain the discrepant association between 
conditions. First, the difference may stem from the nature of inhibition varying between OCD 
and TTM. Differential clinical phenomenology between hair pulling and compulsions may be 
reflected in their respective patterns of RI performance. The full picture of OCD seems to 
involve impaired inhibition at two levels: first, the intrusion of unwanted or irrelevant cognitions 
(i.e., impaired cognitive inhibition) and second the repetition of dysfunctional rituals (i.e., 
impaired motor inhibition) which come in direct response to intrusive thoughts (Bohne et al., 
2008). Conversely, cognitive inhibition is largely secondary to the hallmark motor inhibition 
failure of TTM (Bohne et al., 2005). Thus, functionally the two disorders have different styles of 
compulsions: while those with OCD may attempt to reduce distress from intrusive thoughts, 
leading to repetitive and largely non-functional stereotypy, such distressing emotional contexts 
are not as prominent in those with TTM. Though cognitive inhibition deficit was not measured in 
our study, it is conceivable that motor inhibition in OCD (vs. TTM) may encompass differential 
factors (e.g., presence of distressing emotion, and accompanying difficulty in cognitive 
inhibition), which warrants systematic investigation in the future.  
Second, it may be the case that various types of RI are differentially important in 
explaining the symptoms of OCD and TTM. More precisely, inhibitory control and RI, as 
discussed in the introduction, is a broad term and has distinctive subcomponents both 
behaviorally and neurally. The SST is thought to primarily tap into one subset of RI called action 
cancellation, which is the stopping of a motor response already in progress (Eagle et al., 2008). 
The other two forms of RI, action withholding and interference control, may be more or less 
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useful in capturing the diverse nature of OCRD symptoms (Friedman & Miyake, 2004). This 
possibility can and most likely will be addressed empirically through systematic investigation of 
RI patterns across different OCRD conditions utilizing different measures. As our data stand, 
however, we cannot resolve the inconsistency between the diagnostic groups but merely point to 
suggestions. 
Third, it may be that within the SSRT, there are subcomponents that are in fact useful in 
measuring symptoms across OCD and TTM. The horse-race model of understanding RI and the 
quantitative measurement of this model, SSRT, will be refined and revised to enable new ways 
of extracting SST data. Thus, while the concept behind the SST may be valid for OCD and TTM 
in that both disorders need to inhibit prepotent motor responses, the SSRT may not be the only 
metric within the task that can capture dysfunction in both disorders. Particularly, new methods 
of analysis that take into account error monitoring and post-response slowing may be fruitful in 
uncovering similarities and differences in OCRDs (Li et al., 2008). For instance, models of 
performance monitoring and decisional making can help to inform why compulsive behavior is 
continued despite significant interference and distress (Montague et al., 2012).  
Lastly, in terms of measurement, perhaps our main methods of measuring overt OC-
symptoms (i.e., self-report YBOCS and MGH) did not capture a range of symptoms wide 
enough with which SSRT could correlate. Although the self-report YBOCS is considered to be 
quite reliable, participants do tend to under-report symptoms (Federici et al., 2010) and this may 
also be the case for the MGH. For instance, there are important features of trichotillomania that 
may not be thoroughly assessed on the MGH such as success in resisting pulling urges, or ability 
to stop pulling when having notices a pulling episode.  
34 
 
Despite the lack of uniformity of findings for conditions along the OCRD spectrum, these 
findings may in fact have important clinical implications. If there truly is a differential pattern of 
OC-symptom to RI performance relationship, then the depending on the specific type of OCRD a 
client presents with, there may be more/less important aspects of inhibitory control that are 
driving symptoms. For instance, we failed to find robust relationships between the obsessional 
content of OCD and any features of RI; thus, clients with OCD whose distress comes mostly 
from obsessional intrusions may see less benefit from treatment programs centered around 
inhibitory control. Likewise, it may be that action withholding is more important than action 
cancellation in TTM; Bohne et al (2008), for instance, found motor inhibition deficits in TTM on 
the GNG task, which measures action withholding, but not for OCD. Clinically, this proscribes 
treatment for TTM in line with habit reversal therapy, which is targeted to establish incompatible 
behaviors that can prohibit the initiation of maladaptive motor responses (Woods et al., 2006). 
Further investigation, however, is needed to uncover the specificity of different RI mechanisms 
to specific OCRDs.   
This study is not without its limitations. Most notably, our sample size for those with 
TTM, and for those with both OCD and TTM are quite low. While some relationships showed a 
trending pattern of significance, more broad statements about the relationships between variables 
should be made with a sample with higher power. Additionally, our predominantly white sample 
may preclude the generalizability of our results. Despite the low sample used here, however, our 
participants were from the community and were thoroughly assessed with DSM-5 criteria from 
the ADIS-5; thus, results may be more relevant than having used an analogue sample.  
 Second, this study may suffer from a small measurement battery which lacks any 
clinician-rated measurement. The core battery used to assess our primary hypothesis had one 
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cognitive measure, one measure of OCD and one measure of hair pulling severity. Thus, any 
features of RI or OCRD symptoms not touched upon in this brief battery would simply be absent 
in analysis. Future research will undoubtedly explore the cognitive profile of OCRDs using 
larger and more fully built assessment batteries.  
Despite the limitations, these findings are important in several ways. First, our RI data 
were in a comparable range to other studies that have used the SST in OCD and TTM 
(Chamberlain et al, 2006). This goes to show that SSRT can indeed be measured reliably across 
multiple clinical samples. Second, these data do inform the specificity and value of SSRT on 
describing OCRDs. Namely, the data show that amongst those with OCD, RI is indeed more 
attributable to OCD symptoms than to comorbid depression, and these findings may help to 
inform future evidence-based treatments. Additionally, the lack of correlation between SSRT and 
three subscales of impulsivity help refine our understanding of a distinction between inhibitory 
control as measured by the SST and broader impulsive behavior. These data can inform future 
avenues of research on what symptoms may lend themselves to cognitive assessment, and what 
cognitive batteries may be beneficial in exploring OCRDs. 
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Appendix A – Tables 
Table 1.  
 
Demographic Characteristics 
 
Whole Sample 
(n = 49) 
OCD group 
(n = 27) 
TTM group 
(n = 13) 
Mixed Diagnosis 
(n = 9) 
F or χ2 
Age [M(SD)] 29.59(10.8) 28.04 (10.74) 31.77 (12.262) 31.11 (9.02) ns 
Sex      
   Male 32.7% (n = 16) 33.3% (n = 9) 15.4% (n = 2) 55.6% (n = 5) ns 
   Female 67.3% (n = 33) 66.7% (n = 18) 84.6% (n = 11) 44.4% (n = 4) ns 
Race      
   Caucasian 81.6% (n = 40) 84.6% (n =22) 84.6% (n = 11) 77.8% (n = 7) ns 
   African     
   American 
10.2% (n = 5) 7.7% (n = 2) 15.4% (n = 2) 11.1% (n = 1) ns 
   Two or more    
   races 
6.1% (n = 3) 7.7% (n =2)  0% (n = 0) 11.1% (n = 1) ns 
Hispanic/Latino 2.0% (n = 1) 3.7% (n = 1) n/a n/a ns 
WASI-2 105.04(10.45) 103.52(10.66) 107.66(9.25) 105.87(11.90) ns 
Comorbidity      
   PD 6.1% (n = 3) 7.4% (n = 2) 0% (n = 0) 11.1% (n = 1) ns 
   Agoraphobia 8.2% (n = 4) 7.4% (n = 2) 15.4% (n = 2) 0% (n = 100) ns 
   SoP    44.9% (n = 22) 51.9% (n = 14) 30.8% (n = 4) 44.4% (n = 4) ns 
   SA 6.1% (n = 3) 0% (n = 0) 23.1% (n = 3) 0% (n = 0) 8.849* 
   GAD 57.1% (n = 28) 66.7% (n = 18) 38.5% (n = 5) 55.6% (n = 5) ns 
   BDD 6.1% (n = 3) 3.7% (n = 1) 0% (n = 0) 22.2% (n = 2) ns 
   Phobia 16.3% (n = 8) 7.4% (n = 2) 30.8% (n = 4) 22.2% (n = 2) ns 
   PTSD 18.4% (n = 9) 3.7% (n = 1) 30.8% (n = 4) 44.4% (n = 4) 9.287** 
   MDD 42.9% (n = 21) 40.7% (n = 11) 38.5% (n = 5) 55.6% (n = 5) ns 
   PDD 8.2% (n = 4) 11.1% (n = 3) 7.7% (n = 1) 0% (n = 0) ns 
   IAD 2% (n = 1) 0% (n = 0) 0% (n = 0) 11.1% (n = 1) ns 
   AUD 2% (n = 1) 0% (n = 0) 7.7% (n =1) 0% (n = 0) ns 
   SUD  6.1% (n = 3) 0% (n = 0) 0% (n = 0) 33.3% (n = 3) 14.203*** 
   ADHD 14.3% (n = 7) 11.1% (n = 3) 7.7% (n = 1) 33.3% (n = 3) ns 
   BN 4.1% (n = 2) 3.7% (n = 1) 7.7% (n =1) 0% (n = 0) ns 
   Other  6.1% (n =3) 7.4% (n = 2) 0% (n = 0) 11.1% (n = 1) ns 
*p < 0.05; **p < 0.01; ***p < 0.001. 
Abbreviations: FSIQ-2=Full-Scale IQ, PD=Panic Disorder, SoP=Social Phobia, SA=Separation Anxiety, 
GAD=Generalized Anxiety Disorder, BDD=Body Dysmorphic Disorder, PTSD=Post-Traumatic Stress Disorder, 
IAD=Illness Anxiety Disorder, MDD/PDD=Major/Persistent Depressive Disorder, AUD= Alcohol Use Disorder, 
SUD=Substance Use Disorder, ADHD=Attention Deficit Hyperactivity Disorder, BN=Bulimia Nervosa. 
Note: WASI-2 Full-Scale IQ Scores are derived from Matrix Reasoning and Vocabulary subtests. 
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Table 2. 
 
Measures Used in This Project 
 
 
 
 
 
 
 
 
Construct Measure Type of Measure 
Diagnostic Status Anxiety Disorders Interview 
Schedule for DSM-5 Disorders 
(ADIS-5) 
Structured interview 
Illness Severity (OCD) Yale-Brown Obsessive 
Compulsive Scale (Y-BOCS) 
Self-Report Version 
Self-report (Qualtrics) 
Illness Severity (TTM) Massachusetts General Hospital 
Hairpulling Scale (MGH) 
Self-report (Qualtrics) 
Response Inhibition Stop-Signal Task (SST) Computerized paradigm 
Depression Beck Depression Inventory II 
(BDI-II) 
Self-report (paper) 
Depression Depression Anxiety Stress Scale 
(DASS) 
Self-report (Qualtrics) 
Anxiety & Stress Depression Anxiety Stress Scale 
(DASS) 
Self-report (Qualtrics) 
Impulsivity Barratt Impulsiveness Scale 
(BIS-11) 
Self-report (Qualtrics) 
Incompleteness Obsessive-Compulsive Trait 
Core Dimensions Questionnaire 
(OC-TCDQ) 
Self-report (Qualtrics) 
Life Impairment Sheehan Disability Scale (SDS) Self-report (Qualtrics) 
Overall Intellectual Functioning Wechsler Abbreviated Scale of 
Intelligence II (WASI-II) 
Intelligence assessment 
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Table 3.  
 
Symptom Characteristics 
 
OCD group  
(n = 27) 
TTM group  
(n = 13) 
Mixed Diagnosis 
(n = 9) 
F p 
Post 
-hoc 
 M(SD) M(SD) M(SD)    
OCRD Symptoms       
   YBOCS-T 22.82(5.27) n/a 22.00(4.66) .170 .683  
   YBOCS-O 11.12(3.58) n/a 10.77(2.33) .084 .774  
   YBOCS-C 11.66(2.84) n/a 11.22(2.68) .169 .683  
   MGH-T n/a 17.07(4.42) 18.11(5.13) .255 .619  
SST Variables       
   SSRT 224.65(43.18) 221.14(40.67) 224.71(54.82) .029 .971  
   SSD 432.29(145.57) 372.28(164.13) 356.47(177.86) 1.098 .342  
   goRT 658.07(130.32) 594.52(134.37) 582.57(146.43) 1.566 .220  
Symptom Variables       
   DASS-D 13.18(11.47) 11.07(9.36) 12.88(12.41) .162 .851  
   DASS-A 13.92(8.06) 6.92(5.86) 11.55(10.85) 3.249 .048* 1>2a 
   DASS-S 19.92(9.99) 12.46(8.45) 20.44(10.38) 2.945 .063  
Additional Symptoms       
   BIS-11 AI 25.81(6.62) 12.92(8.47) 18.33(11.29) 11.709 <.001*** 1>2 
   BIS-11 MI 27.88(8.16) 12.61(8.75) 24.77(8.91) 12.621 <.001*** 1,3>2 
   BIS-11 NPI 18.40(6.52) 14.46(8.23) 14.33(6.02) 2.016 .145  
   OCTDCQ-HA 21.07(4.13) 16.69(3.17) 19.66(5.09) 5.015 .011* 1>2 
   OCTDCQ-I 18.85(4.99) 18.92(4.03) 21.77(4.63) 1.405 .256  
   SDS-GI 25.29(5.63) 22.61(5.47) 25.33(5.14) 1.138 .329  
*p < 0.05; **p < 0.01; ***p < 0.001. 
a 1 = OCD group, 2 = TTM group, 3 = Mixed group. 
Abbreviations: YBOCS-T=Yale-Brown Obsessive-Compulsive Scale Total Scores, YBOCS-O= Yale-Brown 
Obsessive-Compulsive Scale Obsessional Severity, YBOCS-C=Yale-Brown Obsessive-Compulsive Scale 
Compulsion Severity, MGH-T=Massachusetts General Hairpulling Scale Severity, SSRT= Stop-Signal Reaction 
Time, SSD=Stop-Signal Delay, goRT=Mean reaction time on Go trials, DASS-D=Depression, DASS-A=Anxiety, 
DASS-S=Stress, BIS-11 AI= Attentional Impulsivity, BIS-11 MI= Motor Impulsivity, BIS-11 NPI=Non-Planning 
Impulsivity, HA=Harm Avoidance, OCTDCQ-HA=Harm Avoidance, OCTDCQ-I=Incompleteness, SDS-
GI=Global Impairment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.  
Correlations among OCRD Symptoms, Depression and SST Indices in an Overall Sample  
 
 
 
 
 
 
 
 
*p < 0.05; **p < 0.01; ***p < 0.001. 
Abbreviations: p.RS=Probability of Commission, SSD=Stop Signal Delay, goRT=Mean Reaction Time on go Trials, Go-%=Correct go-trial percentage, Omis-
%=Omission Percentage, DASS-D=Depression, OCRD Severity=Z-centered YBOCS and MGH scores, DASS-D=Depression. 
Measure 1 2 3 4 5 6 7 8 
1. p.RS ‒ 
 
‒ ‒ ‒ ‒ ‒ ‒ ‒ 
2. SSD -.625
*** ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
3. SSRT .232 -.594
*** ‒ ‒ ‒ ‒ ‒ ‒ 
4. Commission RT -.547
*** .917*** -.332* ‒ ‒ ‒ ‒ ‒ 
5. goRT -.644
*** .965*** -.363* .954*** ‒ ‒ ‒ ‒ 
6. Go-% -.102 -.216 -.085 -.252 -.287
* ‒ ‒ ‒ 
7. Omis-% -.018 .319
* .050 .362* .392** -.974** ‒ ‒ 
8. OCRD Severity -.059 .231 -.005 .250 .262 -.024 .073 ‒ 
9. DASS-D .058 .260 -.245 .193 .221 -.223 .275 .066 
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Table 5.  
 
Bivariate correlations among OCRD Symptoms, Depression and SST indices in OCD and TTM 
*p < 0.05; **p < 0.01; ***p < 0.001. 
Abbreviations: p.RS=Probability of Commission, SSRT= Stop-Signal Reaction Time, SSD=Stop-Signal Delay, goRT=Mean reaction time on Go trials, Go-
%=Correct go-trial percentage, Omis-%=Omission Percentage, YBOCS-T=Yale-Brown Obsessive-Compulsive Scale Total Scores, YBOCS-O= Yale-Brown 
Obsessive-Compulsive Scale Obsessional Severity, YBOCS-C=Yale-Brown Obsessive-Compulsive Scale Compulsion Severity, DASS-D=Depression, MGH-
T=Massachusetts General Hairpulling Scale Severity. 
OCD 
 TTM 
Measure 1 2 3 4 5 6 7 8 9 10 11 12 
1. p.RS ‒ -.749
** .525 -.618* -.753** .038 -.159 n/a n/a n/a -.112 -.340 
2. SSD -.479
* ‒ -.791** .916*** .983*** -.394 .511 n/a n/a n/a .368 .291 
3. SSRT -.052 -.494
** ‒ -.569* -.666* .358 -.460 n/a n/a n/a -.280 -.255 
4. Commission RT -.459
* .915*** -.248 ‒ .945*** -.272 .384 n/a n/a n/a .487 .152 
5. goRT -.550
** .957*** -.222 .944*** ‒ -.385 .495 n/a n/a n/a .363 .285 
6. Go-% .193 -.574
** -.058 -.587** -.628*** ‒ -.975*** n/a n/a n/a -.014 -.271 
7. Omis-% -.326 .628
*** -.048 .664*** .686*** -.946*** ‒ n/a n/a n/a .066 .260 
8. YBOCS-T .178 -.002 .326 .041 .103 -.340 .323 ‒ n/a n/a n/a n/a 
9. YBOCS-O -.038 .155 .136 .057 .216 -.366 .334 .862
*** ‒ n/a n/a n/a 
10. YBOCS-C .378 -.197 .433
* .005 -.081 -.170 .179 .770*** .341 ‒ n/a n/a 
11. MGH-T n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a ‒ .247 
12. DASS-D .118 .251 -.299 .181 .176 -.046 .171 -.018 -.055 .036 n/a ‒ 
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Table 6.   
 
Interaction of Diagnostic Group on the Relationship between OCRD Symptoms and SSRT 
*p < 0.05; **p < 0.01; ***p < 0.001. 
Abbreviations: DASS-D=Depression, DASS-A=Anxiety, DASS-S=Stress, OCD=Obsessive Compulsive Disorder, TTM=Trichotillomania, Mixed 
Diagnosis=OCD + TTM Diagnoses, OCRD Severity=z-centered YBOCS and MGH scores. 
DV: SSRT 
Model 1 
R2 = .117, F(4, 43) = 1.425, p = .242 
Model 2 
R2 Δ = .008, F(7, 40) = .815, p = .580 
Model 3 
R2 Δ = .192, F(9, 38) = 1.959, p = .072 
Variable B SE B  t p B SE B  t p B SE B  t p 
Gender 16.84 13.33 .183 1,26 .213 17.02 14.95 .185 1.13 .262 10.34 13.79 .112 .750 .458 
DASS-D -.555 .785 -.139 -.707 .483 -.461 .835 -.116 -.552 .584 .060 .780 .015 .077 .939 
DASS-A .780 1.142 .153 .683 .498 .559 1.24 .109 .448 .657 1.29 1.16 .254 1.10 .274 
DASS-S -1.29 1.10 -.300 -1.17 .247 -1.36 1.17 -.317 -1.16 .252 -2.44 1.11 -.566 -2.188 .035* 
OCD vs. TTM      -7.46 6.92 -.076 -.441 .661 -11.56 15.48 -.118 -.747 .460 
OCD vs. Mixed Diagnosis      -2.84 18.16 -.026 -.157 .876 15.08 17.76 .136 .849 .401 
OCRD Severity      2.816 7.08 .065 .398 .693 17.10 8.06 .393 2.12 .041* 
Interaction: OCD vs. TTM           -29.72 14.88 -.328 -1.99 .053 
Interaction: OCD vs. Mixed           -52.47 17.34 -.515 -3.025 .004** 
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Table 7.  
 
Hierarchical Regression used to predict SSRT scores using OCRD Severity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*p < 0.05; **p < 0.01; ***p < 0.001. 
Abbreviations: SSRT=Stop-signal reaction time, YBOCS-T=Yale-Brown Obsessive-Compulsive Scale Total Scores, YBOCS-O= Yale-Brown Obsessive-
Compulsive Scale Obsessional Severity, YBOCS-C=Yale-Brown Obsessive-Compulsive Scale Compulsion Severity, DASS-D=Depression, DASS-A=Anxiety, 
DASS-S=Stress, MGH=Massachusetts General Hairpulling Scale Total Severity, OCD=Obsessive Compulsive Disorder, TTM=Trichotillomania, OCRD 
Severity=z-centered YBOCS and MGH scores. 
 
DV: SSRT 
Model 1 
 
Model 2 
 
Variable B SE B  t p B SE B  t p 
Whole 
Sample 
 R2 =.117, F(4, 43) = 1.425, p = .242 R2 Δ =.003, F(5, 42) = 1.151, p = .349 
Gender 16.848 13.334 .183 1.264 .213 18.133 13.832 .197 1.311 .197 
DASS-D -.555 .785 -.139 -.707 .483 -.537 .794 -.135 -.676 .503 
DASS-A .780 1.142 .153 .683 .498 .678 1.180 .133 .575 .569 
DASS-S -1.295 1.103 -.300 -1.175 .247 -1.291 1.114 -.299 -1.159 .253 
OCRD Severity      2.739 6.750 .063 .406 .687 
OCD 
 R2 =.185, F(4, 21) = 1.191, p = .344 R2 Δ =.112, F(5, 20) = 1.686, p = .184 
Gender 3.312 17.991 .037 .184 .856 9.040 17.426 .102 .519 .610 
DASS-D -.860 1.062 -.231 -.810 .427 -.378 1.046 -.102 -.361 .722 
DASS-A 2.663 1.714 .507 1.554 .135 2.355 1.640 .448 1.436 .166 
DASS-S -2.009 1.654 -.473 -1.215 .238 -2.527 1.601 -.594 -1.578 .130 
YBOCS-T      2.938 1.649 .365 1.782 .090 
OCD 
 R2 =.185, F(4, 21) = 1.191, p = .344 R2 Δ =.207, F(6, 19) = 2.043, p = .109 
Gender 3.312 17.991 .037 .184 .856 7.874 16.633 .088 .473 .641 
DASS-D -.860 1.062 -.231 -.810 .427 -.740 1.020 -.199 -.726 .477 
DASS-A 2.663 1.714 .507 1.554 .135 2.668 1.575 .508 1.694 .107 
DASS-S -2.009 1.654 -.473 -1.215 .238 -2.288 1.533 -.538 -1.493 .152 
YBOCS-O      -.440 2.508 -.037 -.175 .863 
YBOCS-C      7.042 2.848 .473 2.473 .023* 
TTM 
 R2 =.341, F(4, 8) = 1.034, p = .446 R2 Δ =.127, F(5, 7) = 1.230, p = .387 
Gender 10.183 31.647 .094 .322 .756 -2.337 31.913 -.022 -.073 .944 
DASS-D .382 1.534 .088 .249 .809 1.185 1.599 .273 .741 .483 
DASS-A 1.082 2.506 .156 .432 .677 1.948 2.499 .281 .779 .461 
DASS-S -3.343 2.041 -.695 -1.637 .140 -4.246 2.082 -.882 -2.039 .081 
MGH      -3.708 2.871 -.403 -1.291 .238 
Mixed 
Diagnosis 
 R2 =.496, F(4, 4) = .984, p = .506 R2 Δ =.013, F(5, 3) = .622, p = .701 
Gender 48.065 52.068 .462 .923 .408 34.532 76.201 .332 .453 .681 
DASS-D .331 3.312 .075 .100 .925 .603 3.895 .137 .155 .887 
DASS-A -3.285 3.690 -.650 -.890 .424 -2.814 4.522 -.557 -.622 .578 
DASS-S .318 3.248 .060 .098 .927 .001 3.868 .000 .000 1.000 
OCRD Severity      -10.472 36.995 -.189 -.283 .796 
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Table 8.  
 
Whole Sample Correlations of OCRD Severity and SST Indices with Associated Features of OCRDs 
*p < 0.05; **p < 0.01; ***p < 0.001. 
Abbreviations: p.RS=Probability of Commission, SSRT= Stop-Signal Reaction Time, SSD=Stop-Signal Delay, goRT=Mean reaction time on Go trials, Go-
%=Correct go-trial percentage, Omis-%=Omission Percentage, BIS-11 AI= Attentional Impulsivity, BIS-11 MI= Motor Impulsivity, BIS-11 NPI=Non-Planning 
Impulsivity, HA=Harm Avoidance, OCTDCQ-HA=Harm Avoidance, OCTDCQ-I=Incompleteness, SDS-GI=Global Impairment. 
 
 
 
 
 
Measure 1 2 3 4 5 6 7 8 9 10 11 12 13 
1. p.RS ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
2. SSD -.625
*** ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
3. SSRT .232 -.594
*** ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
4. Commission RT -.547
*** .917*** -.332* ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
5. goRT -.644
*** .965*** -.363* .954*** ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
6. Go-% -.102 -.216 -.085 -.252 -.287
* ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
7. Omis-% -.018 .319
* .050 .362* .392** -.974** ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
8. OCRD Severity -.059 .231 -.005 .250 .262 -.024 .073 ‒ ‒ ‒ ‒ ‒ ‒ 
9. BIS-11 AI -.013 .132 -.045 .080 .138 -.142 .147 .061 ‒ ‒ ‒ ‒ ‒ 
10. BIS-11 MI .106 -.132 .093 -.205 -.123 -.195 .196 .077 .372
** ‒ ‒ ‒ ‒ 
11. BIS-11 NPI -.026 -.037 .048 -.087 -.027 -.027 .027 -.074 .465
** .616*** ‒ ‒ ‒ 
12. OCTDCQ-HA -.083 .404
** -.239 .312* .390** -.237 .289* .261 .605*** .225 .260 ‒ ‒ 
13. OCTDCQ-I -.224 .384
** -.123 .340* .406** -.320* .354* .206 .443** .229 .122 .717*** ‒ 
14. SDS-GI -.112 .169 -.047 .134 .179 -.015 .045 .137 .489
*** .357* .327* .478*** .428** 
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Table 9.  
 
Correlations of OCRD Severity and SST Indices with Associated Features of OCRDs in Both OCD and TTM 
*p < 0.05; **p < 0.01; ***p < 0.001. 
Abbreviations: p.RS=Probability of Commission, SSRT= Stop-Signal Reaction Time, SSD=Stop-Signal Delay, goRT=Mean reaction time on Go trials, Go-
%=Correct go-trial percentage, Omis-%=Omission Percentage, BIS-11 AI= Attentional Impulsivity, BIS-11 MI= Motor Impulsivity, BIS-11 NPI=Non-Planning 
Impulsivity, HA=Harm Avoidance, OCTDCQ-HA=Harm Avoidance, OCTDCQ-I=Incompleteness, SDS-GI=Global Impairment, YBOCS-T=Yale-Brown 
Obsessive-Compulsive Scale Total Scores, YBOCS-O= Yale-Brown Obsessive-Compulsive Scale Obsessional Severity, YBOCS-C=Yale-Brown Obsessive-
Compulsive Scale Compulsion Severity, MGH-T=Massachusetts General Hairpulling Scale Severity, YBOCS-T=Yale-Brown Obsessive-Compulsive Scale 
Total Scores, YBOCS-O= Yale-Brown Obsessive-Compulsive Scale Obsessional Severity, YBOCS-C=Yale-Brown Obsessive-Compulsive Scale Compulsion 
Severity.
OCD 
 TTM 
Measure 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. p.RS ‒ -.749
** .525 -.618* -.753** .038 -.159 n/a n/a n/a -.112 -.172 -.014 -.235 -.144 -.133 -.461 
2. SSD -.479
* ‒ -.791** .916*** .983*** -.394 .511 n/a n/a n/a .368 .375 .088 .095 .516 .236 .564* 
3. SSRT -.052 -.494
** ‒ -.569* -.666* .358 -.460 n/a n/a n/a -.280 .010 -.015 -.183 -.479 -.213 -.221 
4. Commission RT -.459
* .915*** -.248 ‒ .945*** -.272 .384 n/a n/a n/a .487 .379 -.061 -.173 .378 .016 .509 
5. goRT -.550
** .957*** -.222 .944*** ‒ -.385 .495 n/a n/a n/a .363 .468 .110 .068 .489 .230 .623* 
6. Go-% .193 -.574
** -.058 -.587** -.628*** ‒ -.975*** n/a n/a n/a -.014 -.569* -.590* -.236 -.526 -.576* -.327 
7. Omis-% -.326 .628
*** -.048 .664*** .686*** -.946*** ‒ n/a n/a n/a .066 .551 .574* .205 .610 .611* .413 
8. YBOCS-T .178
 -.002 .326 .041 .103 -.340 .323 ‒ n/a n/a n/a n/a n/a n/a n/a n/a n/a 
9. YBOCS-O -.038 .155 .136 .057 .216 -.366 .334 .862
*** ‒ n/a n/a n/a n/a n/a n/a n/a n/a 
10. YBOCS-C .378 -.197 .433
* .005 -.081 -.170 .179 .770*** .341 ‒ n/a n/a n/a n/a n/a n/a n/a 
11. MGH-T n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a ‒ .073 -.355 -.649
* .278 .040 .290 
12. BIS-11 AI .108 -.067 -.152 -.249 -.132 .146 -.077 .121 .228 -.063 n/a ‒ .572
* .247 .433 .674* .797*** 
13. BIS-11 MI -.034 -.213 .247 -.243 -.161 .086 -.029 .211 .201 .137 n/a .452
* ‒ .569* .373 .580* .418 
14. BIS-11 NPI .130 -.211 .178 -.202 -.178 .060 -.031 .085 .026 .124 n/a .392
* .739*** ‒ .221 .319 .208 
15. OCTDCQ-HA .145 .270 -.318 .049 .194 -.225 .215 .367 .478
* .078 n/a .495** .176 .019 ‒ .666* .567* 
16. OCTDCQ-I -.342 .516
** -.203 .407* .510** -.409* .388* .305 .453* -.005 n/a .047 .089 -.217 .397* ‒ .706** 
17. SDS-GI .301 -.280 .171 -.239 -.257 .195 -.190 .044 -.070 .169 n/a .234 .420
* .296 .141 .090 ‒ 
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Table 10.  
 
Relationship between Individual Items on the YBOCS with SST Variables in an OCD Group 
*p < 0.05; **p < 0.01; ***p < 0.001. 
Abbreviations: p.RS=Probability of Commission, SSRT= Stop-Signal Reaction Time, SSD=Stop-Signal Delay, Com.RT=Commission Reaction Time, 
goRT=Mean reaction time on Go trials, Go-%=Correct go-trial percentage, Omis-%=Omission Percentage. 
 
Item p.RS SSD SSRT Com.RT goRT Go-% Omis-% 
Obsession Items 
       
    Time occupied by obsessive thoughts .053 .146 .007 .032 .163 -.196 .160 
    Interference from obsessions .042 -.123 .283 -.166 -.047 -.099 .089 
    Distress from obsessions -.038 .081 .108
 -.053 .124 -.359 .338 
    Effort to resist obsessions  -.093 .291 .066 .303 .349 -.593
*** .543** 
    Control over obsessions  -.128 .228 .090 .119 .285 -.241 .231 
Compulsion Items        
    Time spent compulsions .095 -.061 .262 .060 .013 -.296 .338 
    Interference from compulsions .294 -.147 .469
* -.032 -.012 -.112 .079 
    Distress from prevented compulsions .482
* -.345 .402* -.160 -.254 .216 -.226 
    Effort to resist compulsions .280 -.227 .277 -.047 -.162 -.163 .143 
    Control over compulsions .177 .119 .129 .217 .170 -.240 .300 
Insight .102 .005 .175 .015 .067 -.272 .208 
Avoidance .311 -.156 .288 -.194 -.081 -.241 .213 
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Table 11.  
 
Relationship between Individual Items on the MGH with SST Variables in a TTM Group 
*p < 0.05; **p < 0.01; ***p < 0.001. 
Abbreviations: p.RS=Probability of Commission, SSRT= Stop-Signal Reaction Time, SSD=Stop-Signal Delay, Com.RT=Commission Reaction Time, 
goRT=Mean reaction time on Go trials, Go-%=Correct go-trial percentage, Omis-%=Omission Percentage. 
 
Item p.RS SSD SSRT Com.RT goRT Go-% Omis-% 
Frequency of urges -.257
 .397 -.121 .591* .443 .114 -.025 
Intensity of urges -.508
 .530 -.272 .661* .559* .048 .071 
Ability to control urges -.152 .322 -.226 .325 .324 .027 .037 
Frequency of hairpulling -.074 .317 -.052
 .551 .368 -.173 .240 
Attempts to resist pulling .401 -.022 -.246 -.025 -.096 -.009 -.044 
Control over hairpulling .021 .252 -.343 .218 .208 -.278 .299 
Associated distress .010 .020 -.091 .092 -.001 .111 -.160 
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APPENDIX B – FIGURES 
 
Figure 1. Illustration of the stop-signal task (SST) (Verbruggen & Logan, 2009). In this task, a 
subject is presented with a series of stimuli to respond to (“go-stimuli”) with arrow keys. On 
33% percent of the trials subjects are presented with a “stop-stimuli” (i.e., a beep sound) after a 
very short delay (“stop-signal delay”). Subjects need to withhold a response that has already 
been initiated, and data from these responses are extrapolated into a “Stop-Signal Reaction 
Time,” an index of response inhibition capabilities. 
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Figure 2. Scatterplot illustration of the relationship between SSRT and YBOCS compulsion 
scores among those with OCD. 
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Figure 2. Interaction of diagnostic group (i.e., OCD vs TTM and OCD vs. Mixed Diagnosis) in 
predicting OCRD severity and SSRT. 
 
 
 
 
 
 
190
200
210
220
230
240
250
260
270
280
Low Med High
SS
R
T
OCRD Severity
OCD vs. TTM
Trich OCD
190
200
210
220
230
240
250
260
270
280
Low Med High
SS
R
T
OCRD Severity
OCD vs. Mixed
Mixed OCD
